{Reference Type}: Case Reports
{Title}: Burkitt lymphoma in a scalp region: a case report of it's recurrence in a 13-year-old child.
{Author}: Baniya A;Koirala D;Dahal A;Khadka G;
{Journal}: Ann Med Surg (Lond)
{Volume}: 86
{Issue}: 6
{Year}: 2024 Jun
暂无{DOI}: 10.1097/MS9.0000000000002089
{Abstract}: <B>UNASSIGNED: </B>Burkitt lymphoma (BL) is an aggressive non-Hodgkin lymphoma characterized by chromosome 8 MYC gene translocation. It manifests in three clinical types: immunodeficiency-related, sporadic (nonendemic), and endemic (African), each differing in epidemiology and clinical behavior. Treatment typically involves enrollment in clinical trials or intensive chemotherapy regimens like R-CODOX-M/IVAC. The authors present a case of recurrent BL following treatment.<BR><B>UNASSIGNED: </B>A 13-year-old female presented with a gradually progressive swelling in the left parieto-occipital region. Examination revealed normal vital signs and a Glasgow coma scale, with seronegative findings on investigations. An excision of a subganglion soft tissue tumor was performed, revealing histopathological features suggestive of a small round blue cell tumor. After chemotherapy, the patient experienced a recurrence in the scalp region, diagnosed as BL.<BR><B>UNASSIGNED: </B>While scarce reports exist on BL in the scalp region, cases have been documented in various body locations. Treatment strategies, including chemotherapy and surgery, have shown promising results in managing the disease and improving symptoms.<BR><B>UNASSIGNED: </B>The recurrence of BL is rare, highlighting the importance of vigilance in monitoring patients post-treatment. The authors report a case of recurrent BL in a 13-year-old female, emphasizing the need for continued research and surveillance in managing this aggressive malignancy.